Kallum Titchmarsh
Stock Analyst at Morgan Stanley
(0.03)
# 4,513
Out of 5,131 analysts
20
Total ratings
12.5%
Success rate
-24.99%
Average return
Main Sectors:
Stocks Rated by Kallum Titchmarsh
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| WST West Pharmaceutical Services | Initiates: Equal-Weight | $285 | $275.23 | +3.55% | 1 | Dec 2, 2025 | |
| WAT Waters | Initiates: Equal-Weight | $423 | $396.65 | +6.64% | 1 | Dec 2, 2025 | |
| MTD Mettler-Toledo International | Initiates: Equal-Weight | $1,550 | $1,465.20 | +5.79% | 1 | Dec 2, 2025 | |
| INSP Inspire Medical Systems | Downgrades: Equal-Weight | $105 → $130 | $95.00 | +36.84% | 7 | Dec 2, 2025 | |
| DHR Danaher | Initiates: Overweight | $270 | $235.00 | +14.89% | 1 | Dec 2, 2025 | |
| A Agilent Technologies | Initiates: Overweight | $180 | $145.76 | +23.49% | 1 | Dec 2, 2025 | |
| PEN Penumbra | Maintains: Equal-Weight | $260 → $266 | $315.54 | -15.70% | 8 | Jul 31, 2025 |
West Pharmaceutical Services
Dec 2, 2025
Initiates: Equal-Weight
Price Target: $285
Current: $275.23
Upside: +3.55%
Waters
Dec 2, 2025
Initiates: Equal-Weight
Price Target: $423
Current: $396.65
Upside: +6.64%
Mettler-Toledo International
Dec 2, 2025
Initiates: Equal-Weight
Price Target: $1,550
Current: $1,465.20
Upside: +5.79%
Inspire Medical Systems
Dec 2, 2025
Downgrades: Equal-Weight
Price Target: $105 → $130
Current: $95.00
Upside: +36.84%
Danaher
Dec 2, 2025
Initiates: Overweight
Price Target: $270
Current: $235.00
Upside: +14.89%
Agilent Technologies
Dec 2, 2025
Initiates: Overweight
Price Target: $180
Current: $145.76
Upside: +23.49%
Penumbra
Jul 31, 2025
Maintains: Equal-Weight
Price Target: $260 → $266
Current: $315.54
Upside: -15.70%